Found 15 matching trials
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer N/A Gene expression, the transfer of the genetic code into cellular proteins is...
Show More Location
Maidstone and Tunbridge Wells NHS Trust
Learn More & Join Trial
DARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation) PHASE4 The DARA-MVI Study is a prospective, randomized, controlled, open-label tri...
Show More Status
Active Not Recruiting
Location
Transplant-nephrology department
Learn More & Join Trial
Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection NA This study is a prospective non-randomized controlled study. The purpose of...
Show More Location
Cancer Hospital and Institute, Chinese Academy of Medical Sciences
Learn More & Join Trial
Eparlitozoviril as Adjuvant Therapy for Resectable HCC With MVI PHASE2 Tumor recurrence is the leading cause of death and a major bottleneck for l...
Show More Status
Active Not Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH PHASE1 The aim of this study is to explore the effect of Transarterial Chemoemboli...
Show More Location
Eastern hepatobilliary surgery hospital
Learn More & Join Trial
Adjuvant Therapies for Patients With HCC and MVI PHASE3 Hepatocellular carcinoma (HCC) is a common malignancy, and its incidence is...
Show More Location
Department of Hepatobilliary Surgery, Affiliated Tumor of Guangxi University
Learn More & Join Trial
Use of Ritual Prenatal Multivitamins for Pregnancy NA Prenatal multivitamin/multimineral supplements (MVI) provide important nutr...
Show More Location
Brooklyn College of City University of New York
Learn More & Join Trial
The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. PHASE3 To compare The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patient...
Show More Location
SUN YAT-SEN University Cancer Center
Learn More & Join Trial
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation PHASE2 In this study, researchers will learn more about a drug called felzartamab ...
Show More Location
Loma Linda University Medical Center
Learn More & Join Trial
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. PHASE3 To compare The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinf...
Show More Location
Cancer Center of Sun Yat-Sen University
Learn More & Join Trial